Merck's Keytruda Meets Primary Endpoint in Late-Stage Head and Neck Cancer Trial
marketscreener.com
Merck's Keytruda Meets Primary Endpoint in Late-Stage Head and Neck Cancer Trial
Merck said Tuesday that its Keytruda treatment met the primary endpoint of event-free survival in the late-stage Keynote-689 trial for patients with stage III or IVA resected, locally advanced...
Oct 8, 2024
Pembrolizumab Uses
Identifying Uses for Immunotherapy Across Sarcoma Populations and Subtypes | CancerNetwork
Identifying Uses for Immunotherapy Across Sarcoma Populations and Subtypes | CancerNetwork
cancernetwork.com
1 month ago
Primary Results from the Phase 3 Leap-002 Study: Lenvatinib plus Pembrolizumab versus Lenvatinib as First-Line Therapy for Advanced Hepatocellular Carcinoma | OncLive
Primary Results from the Phase 3 Leap-002 Study: Lenvatinib plus Pembrolizumab versus Lenvatinib as First-Line Therapy for Advanced Hepatocellular Carcinoma | OncLive
onclive.com
Sep 29, 2022
Pembrolizumab KEYNOTE-689 Phase 3 Trial Update for LA-HNSCC at AACR 2025
1:05
Pembrolizumab KEYNOTE-689 Phase 3 Trial Update for LA-HNSCC at AACR 2025
oncologytube.com
Apr 30, 2025
Top videos
How Merck reached new ground in the fight against cancer
7:57
How Merck reached new ground in the fight against cancer
YahooYahoo Finance Video
Jun 5, 2019
FDA Approves Merck?s KEYTRUDA QLEX (pembrolizumab and berahyaluronidase alfa-pmph) Injection for Subcutaneous Use in Adults Across Most Solid Tumor Indications for KEYTRUDA (pembrolizumab)
FDA Approves Merck?s KEYTRUDA QLEX (pembrolizumab and berahyaluronidase alfa-pmph) Injection for Subcutaneous Use in Adults Across Most Solid Tumor Indications for KEYTRUDA (pembrolizumab)
marketscreener.com
7 months ago
Injectable version of cancer drug Keytruda works as well as current IV form: Merck
1:25
Injectable version of cancer drug Keytruda works as well as current IV form: Merck
CNBC
Nov 19, 2024
Pembrolizumab Side Effects
Pembrolizumab (Keytruda): How It Works, Side Effects & What Patients Should Know
14:04
Pembrolizumab (Keytruda): How It Works, Side Effects & What Patients Should Know
YouTubeDEMIRxCARE
43 views4 months ago
💊What is PEMBROLIZUMAB?. Mechanism of Action, Dosage and Side Effects of Pembrolizumab (KEYTRUDA)💊
13:24
💊What is PEMBROLIZUMAB?. Mechanism of Action, Dosage and Side Effects of Pembrolizumab (KEYTRUDA)💊
YouTubeMedicines/Diseases
1.6K viewsJun 4, 2020
Keytruda (pembrolizumab) Benefits & Side effects
1:19
Keytruda (pembrolizumab) Benefits & Side effects
YouTubeariflive
40 views10 months ago
How Merck reached new ground in the fight against cancer
7:57
How Merck reached new ground in the fight against cancer
Jun 5, 2019
YahooYahoo Finance Video
FDA Approves Merck?s KEYTRUDA QLEX (pembrolizumab and berahyaluronidase alfa-pmph) Injection for Subcutaneous Use in Adults Across Most Solid Tumor Indications for KEYTRUDA (pembrolizumab)
FDA Approves Merck?s KEYTRUDA QLEX (pembrolizumab and berahy…
7 months ago
marketscreener.com
Injectable version of cancer drug Keytruda works as well as current IV form: Merck
1:25
Injectable version of cancer drug Keytruda works as well as current …
Nov 19, 2024
CNBC
Merck Scores Two Victories With Keytruda In Women's Cancers
Merck Scores Two Victories With Keytruda In Women's Cancers
Sep 15, 2024
investors.com
How Merck keeps its $31.7 billion cancer drug out of reach of generic competition
1:41
How Merck keeps its $31.7 billion cancer drug out of reach of generi…
1 month ago
MSNMoney Talks News
Merck to create separate cancer business to offset Keytruda patent loss, WSJ reports
Merck to create separate cancer business to offset Keytruda paten…
2 months ago
aol.co.uk
How Cancer Drug Keytruda ( Pembrolizumab) Treats Melanoma
2:38
How Cancer Drug Keytruda ( Pembrolizumab) Treats Melanoma
11.1K viewsOct 27, 2017
YouTubeLighter Side of Cancer
Merck’s Keytruda Is a $30 Billion Cancer Drug — Are Patients Over …
3 weeks ago
childrenshealthdefense.org
Merck CEO: We're doing the right studies to make KeyTruda broadl…
May 11, 2017
CNBC
The blockbuster cancer drug Keytruda can cost over $150,000 | …
4 weeks ago
MSNDana Taylor,USA TODAY
Merck Reaches Nearly $6 Billion Deal for Cancer Biotech Terns
1 month ago
wsj.com
$
Why Merck’s Keytruda Just Became a Lung Cancer Game Changer
May 11, 2017
FortuneSy Mukherjee
Merck braces for Keytruda patent loss with $6.7 billion Terns bet
1 month ago
MSN
Merck Revamps Pharmaceutical Unit, Creating Separate Cancer Bu…
2 months ago
wsj.com
1:30
Keytruda TV Spot, 'The Moment: Begins'
Sep 12, 2021
iSpot.tv
0:52
Moderna, Merck vaccine with Keytruda delays return of deadly s…
Dec 14, 2023
CNBC
4:21
Merck Research Lab CEO on future cancer treatments
Jun 5, 2017
CNBC
Keytruda: How Expanding Use and Site-of-Service Prices Made Keytr…
1 month ago
healthcostinstitute.org
How Merck turned its wonder drug into a blockbuster — and priced o…
1 month ago
icij.org
Merck plans to launch US subcutaneous version of Keytrud…
10 months ago
bluewaterhealthyliving.com
Merck Profit Rises on Strong Keytruda Demand
6 months ago
wsj.com
8:11
Merck CEO Rob Davis on FDA approval of Keytruda injection, na…
7 months ago
MSNCNBC
4:35
Merck's Keytruda gets an upgrade
7 months ago
MSNCNBC
5:12
Will Trump tariffs boost U.S. manufacturing?
Apr 29, 2025
CBS NewsMegan Cerullo
Keytruda (Pembrolizumab) for Mesothelioma: FDA-Approved Drug
3 months ago
asbestos.com
WSJ: Merck Makes $10 Billion Move as Keytruda Patent Expiration Nears
10 months ago
MSNMichael-Paul Kidd
Keytruda Plus Inlyta Gets a New Indication for Kidney Cancer
Apr 26, 2019
cancerhealth.com
11:09
KEYTRUDA® For High-Risk Non-Muscle Invasive Bladder Cancer
869 viewsJan 28, 2020
YouTubeHPR
2:55
How Keytruda Cancer Treatment Works (Update)
84.7K viewsOct 15, 2018
YouTubeLighter Side of Cancer
See more videos
Static thumbnail place holder